Skip to content
DraconiticResearch
Search Sources API
197,787 studies31 sourcesUpdated 53 min ago
Peer-reviewedCC BY 4.0Communications Biology

Albendazole induces ferroptosis through the USP7-GPX4 axis in B-cell acute lymphoblastic leukemia

Abstract

B-cell acute lymphoblastic leukemia (B-ALL) is an aggressive hematological malignancy that still requires the development of novel therapeutic strategies. Here, leveraging a drug-repurposing strategy, we performed a high-throughput screen of 3008 U.S. Food and Drug Administration (FDA)-approved drugs and identified albendazole (ABZ), a benzimidazole anthelmintic, as a potent agent against B-ALL across multiple preclinical models. Mechanistically, ABZ directly binds ubiquitin-specific protease 7 (USP7) and triggers its autophagy-dependent destabilization, subsequently promoting the ubiquitin-proteasome-mediated degradation of glutathione peroxidase 4 (GPX4), thereby inducing ferroptosis in B-ALL. Our study revealed that USP7 directly interacts with and stabilizes GPX4 by removing K48-linked ubiquitin chains, and both proteins are markedly upregulated in B-ALL patients, correlating with poor survival. Collectively, we identify a previously unrecognized USP7-GPX4 axis that governs ferroptosis and show that ABZ, as a novel ferroptosis inducer, triggers ferroptosis by targeting this axis, supporting clinical repurposing of albendazole or therapeutic targeting of USP7-GPX4 to improve B-ALL outcomes.

Related

  1. Lnc-TIM3 promotes acute lymphoblastic leukemia progression through miR-5094-mediated regulation of TIM3
    Jing Sun, Jiou Zhao, Wenfeng Fu +4
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. SMARCA4 MUTATIONS PROMOTE CHEMOTHERAPY RESISTANCE IN T-ACUTE LYMPHOBLASTIC LEUKEMIA THROUGH ALTERED CHROMATIN REMODELING AT AP1-ASSOCIATED REGULATORY REGIONS
    V. Garcia-Hernandez, M. Maqueda, G. Faccincani +10
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  3. Realgar Transforming Solution Triggers Ferroptosis-Associated Death in NB4 Leukemia Cells through Disruption of Iron Homeostasis and Suppression of the SLC7A11/GPX4 Axis
    Zhaorong Yue, Qinghong Liu, Yanni Wang +14
    Biological and Pharmaceutical BulletinPeer-reviewedCC BY-NCFull textPharmacology & toxicologyJ-STAGE
  4. Understanding and clinical approach to early T-cell precursor acute lymphoblastic leukemia
    Hee Young Ju
    Blood researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. B‐Lymphoblastic Leukemia Presenting as Bilateral Ovarian Masses in a 20‐Year‐Old Woman
    Jennifer Cai, David Sin, Marian Varda +2
    Clinical case reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{wang2026albendazole,
  title = {{Albendazole induces ferroptosis through the USP7-GPX4 axis in B-cell acute lymphoblastic leukemia}},
  author = {Hao Wang and Tianwang Guan and Xiaonan Lin and Yingqi Qiu and Zhongjie Huang and Zhao Liang and Peiyun Liao and Honghao Zhang and Caiwen Ou and Yuhua Li},
  journal = {Communications Biology},
  year = {2026},
  month = oct,
  doi = {10.1038/s42003-026-11229-1},
  url = {https://www.nature.com/articles/s42003-026-11229-1},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Albendazole induces ferroptosis through the USP7-GPX4 axis in B-cell acute lymphoblastic leukemia
AU  - Hao Wang
AU  - Tianwang Guan
AU  - Xiaonan Lin
AU  - Yingqi Qiu
AU  - Zhongjie Huang
AU  - Zhao Liang
AU  - Peiyun Liao
AU  - Honghao Zhang
AU  - Caiwen Ou
AU  - Yuhua Li
PY  - 2026
DA  - 2026/10/27
JO  - Communications Biology
DO  - 10.1038/s42003-026-11229-1
UR  - https://www.nature.com/articles/s42003-026-11229-1
AB  - B-cell acute lymphoblastic leukemia (B-ALL) is an aggressive hematological malignancy that still requires the development of novel therapeutic strategies. Here, leveraging a drug-repurposing strategy, we performed a high-throughput screen of 3008 U.S. Food and Drug Administration (FDA)-approved drugs and identified albendazole (ABZ), a benzimidazole anthelmintic, as a potent agent against B-ALL across multiple preclinical models. Mechanistically, ABZ directly binds ubiquitin-specific protease 7 (USP7) and triggers its autophagy-dependent destabilization, subsequently promoting the ubiquitin-proteasome-mediated degradation of glutathione peroxidase 4 (GPX4), thereby inducing ferroptosis in B-ALL. Our study revealed that USP7 directly interacts with and stabilizes GPX4 by removing K48-linked ubiquitin chains, and both proteins are markedly upregulated in B-ALL patients, correlating with poor survival. Collectively, we identify a previously unrecognized USP7-GPX4 axis that governs ferroptosis and show that ABZ, as a novel ferroptosis inducer, triggers ferroptosis by targeting this axis, supporting clinical repurposing of albendazole or therapeutic targeting of USP7-GPX4 to improve B-ALL outcomes.
SN  - 2399-3642
ER  -